Onesource Specialty Pharma enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
17,991——
19.841.1165
1,2761,276772
19,247——
1,2561,235606
₹1,679.22——
7,1977,1086,652
17.7%18.0%11.6%
0.07×——
11.43×——
48.62×——
178.84×——
Reference items — trailing FY values
1,6841,4221,445
396304467
10825.1193
—8.5−21.5
−561−561−21.5
—−584−115
—5690.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ONESOURCE₹1,569.60

Onesource Specialty Pharma Ltd.

· Pharma & Health
₹ CrorePeersSTARDIVISLABGLANDPFIZERPOLYMEDRAINBOWKIMSJUBLPHARMAMcap ₹17,991 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——17,990.8
- Cash, Equiv & ST Investments165.441.119.8
+ Total Debt771.61,276.31,276.3
Enterprise Value——19,247.2
Net Debt (memo)606.21,235.21,256.5
EV per Share——1,679.22
Total Capital6,652.27,107.67,197.2
Total Debt/Total Capital11.6017.9617.73
Total Debt/EV——0.07
EV/Sales——11.43
EV/EBITDA——48.62
EV/EBIT——178.84
Reference Items — Trailing FY Values
Sales1,444.91,421.61,683.8
EBITDA466.5304.2395.9
EBIT192.625.1107.6
Operating Cash Flow-21.58.5—
Free Cash Flow-21.5-560.5-560.5
FCFF (free cash flow to the firm)-115.4-584.1—
Capital Expenditure0.0569.1—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.